Urokinase type plasminogen activator (uPA) converts plasminogen to plasmin and is highly chemotactic for many cell types. We examined, using recombinant wild type and mutated forms of uPA, the extent to which its proteolytic properties, its growth-like domain (GFD) and/or interactions with the specific receptor (uPAR) contribute to the chemotactic activity towards vascular smooth muscle cells (SMC). Recombinant wild type uPA (r-uPA) stimulated cell migration nearly 5.8-fold, inactive r-uPA with a mutation in the catalitic domain (r-uPA(H/Q)), 3-fold, uPA without growth factor like domain (r-uPA(GFD-)), 2.6-fold, and a form containing both mutations (r- uPA(H/Q, GFD-), 3.3-fold. All recombinant forms of uPA, wild type and those with mutations were equally and highly effective (IC50~20 nM) in displacing 125I-r-uPA bound to SMC. These results indicate that additional mechanisms, not dependent on uPA's proteolytic activity or the binding ability of its GFD to uPAR, are the major contributors to its chemotactic action on SMC.
|Original language||English (US)|
|Number of pages||13|
|Journal||Journal of Receptor and Signal Transduction Research|
|State||Published - Jan 1 1999|
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology